BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dong W, Zhang T, Wang ZG, Liu H. Clinical outcome of small hepatocellular carcinoma after different treatments: A meta-analysis. World J Gastroenterol 2014; 20(29): 10174-10182 [PMID: 25110446 DOI: 10.3748/wjg.v20.i29.10174]
URL: https://www.wjgnet.com/1007-9327/full/v20/i29/10174.htm
Number Citing Articles
1
Wei-Ju Huang, Yung-Ming Jeng, Hong-Shiee Lai, Fang-Yu Bonnie Sheu, Po-Lin Lai, Ray-Hwang Yuan. Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinomaLangenbeck's Archives of Surgery 2015; 400(6): 725 doi: 10.1007/s00423-015-1329-4
2
Cody R. Criss, Mina S. Makary. Recent Advances in Image-Guided Locoregional Therapies for Primary Liver TumorsBiology 2023; 12(7): 999 doi: 10.3390/biology12070999
3
Yih-Jyh Lin, Chia-Ni Lin, Tannaz Sedghi, Sylvia H. Hsu, Cary P. Gross, Jung-Der Wang, Shi-Yi Wang, Nader Hanna. Treatment patterns and survival in hepatocellular carcinoma in the United States and TaiwanPLOS ONE 2020; 15(10): e0240542 doi: 10.1371/journal.pone.0240542
4
Qingsong Deng, Minglian He, Chunchuan Fu, Kai Feng, Kuansheng Ma, Leida Zhang. Radiofrequency ablation in the treatment of hepatocellular carcinomaInternational Journal of Hyperthermia 2022; 39(1): 1052 doi: 10.1080/02656736.2022.2059581
5
Garrett Richard Roll, John Paul Roberts. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set2019; : 1541 doi: 10.1016/B978-0-323-40232-3.00132-1
6
Biao Yang, Rui-yu Zan, Shi-yu Wang, Xiang-lian Li, Mao-ling Wei, Wen-hao Guo, Xin You, Jing Li, Zheng-yin Liao. Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: a meta-analysis of randomized controlled trialsWorld Journal of Surgical Oncology 2015; 13(1) doi: 10.1186/s12957-015-0516-7
7
Jun Xie, Chunyao Zheng, Jinliang Xie, Fangfei Wang, Dingwei Liu, Rong Zeng, Chensong Yu, Sihai Chen. No significant relationship exists between tumor size and prognosis in distant metastatic hepatocellular carcinoma: a propensity score matching analysis based on SEER databaseBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02355-1
8
Nir Rozenblum, Evelyne Zeira, Viviana Scaiewicz, Baruch Bulvik, Svetlana Gourevitch, Hagit Yotvat, Eithan Galun, S. Nahum Goldberg. Oncogenesis: An “Off-Target” Effect of Radiofrequency AblationRadiology 2015; 276(2): 426 doi: 10.1148/radiol.2015141695
9
Olivier Sutter, Amina Fihri, Rafik Ourabia-Belkacem, Nicolas Sellier, Abou Diallo, Olivier Seror. Real-Time 3D Virtual Target Fluoroscopic Display for Challenging Hepatocellular Carcinoma Ablations Using Cone Beam CTTechnology in Cancer Research & Treatment 2018; 17: 153303381878963 doi: 10.1177/1533033818789634
10
Robert J. Wong, Aijaz Ahmed, Robert G. Gish. Elevated Alpha-FetoproteinClinics in Liver Disease 2015; 19(2): 309 doi: 10.1016/j.cld.2015.01.005
11
Zhimei Huang, Yangkui Gu, Shaoyong Wu, Chunxiao Lai, Xiuchen Wang, Jinhua Huang. Computed tomography-guided radiofrequency ablation of the retained iodized oil after simultaneous combination with transarterial embolization in small recurrent or residual hepatocellular carcinomaJournal of Interventional Medicine 2020; 3(1): 49 doi: 10.1016/j.jimed.2020.01.008
12
Qiao Zhang, Feng Xia, Hengyi Gao, Zhenheng Wu, Wenjing Cao, Qingfeng Xiang, Zhifeng Guan, Yang Su, Weiqiao Zhang, Weiqiang Chen, Ali Mo, Shuqun Li. Circulating Tumor Cells as an Indicator of Treatment Options for Hepatocellular Carcinoma Less Than or Equal to 3 cm in Size: A Multi-Center, Retrospective StudyFrontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.895426
13
Toshiro Masuda, Toru Beppu, Hirohisa Okabe, Hidetoshi Nitta, Katsunori Imai, Hiromitsu Hayashi, Akira Chikamoto, Kenichiro Yamamoto, Satoshi Ikeshima, Masafumi Kuramoto, Shinya Shimada, Hideo Baba. Predictive factors of pathological vascular invasion in hepatocellular carcinoma within 3 cm and three nodules without radiological vascular invasionHepatology Research 2016; 46(10): 985 doi: 10.1111/hepr.12637
14
Philippe Rochigneux, Jean-Charles Nault, Françoise Mallet, Anne-Sophie Chretien, Nathalie Barget, Alejandro J. Garcia, Lucie Del Pozo, Valérie Bourcier, Lorraine Blaise, Véronique Grando-Lemaire, Gisèle N’Kontchou, Pierre Nahon, Olivier Seror, Marianne Ziol, Nathalie Ganne-Carrié, Daniel Olive. Dynamic of systemic immunity and its impact on tumor recurrence after radiofrequency ablation of hepatocellular carcinomaOncoImmunology 2019; 8(8) doi: 10.1080/2162402X.2019.1615818
15
Zhaonan Li, Dechao Jiao, Xinwei Han, Guangyan Si, Yahua Li, Juanfang Liu, Yanneng Xu, Bo Zheng, Xun Zhang. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinomaCancer Imaging 2020; 20(1) doi: 10.1186/s40644-020-0294-5
16
Youqing Wang, Luyao Zhang, Fang Han, Runhua Li, Yongran Cheng, Xiyi Jiang, Liangyou Wang, Jinfei Chen, Jianguang Ji, Yuhua Zhang, Tianhui Chen. Using Period Analysis to Timely Assess and Predict 5-Year Relative Survival for Liver Cancer Patients From Taizhou, Eastern ChinaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.920094
17
Nir Rozenblum, Evelyne Zeira, Viviana Scaiewicz, Baruch Bulvik, Svetlana Gourevitch, Hagit Yotvat, Eithan Galun, S. Nahum Goldberg. Oncogenesis: An “Off-Target” Effect of Radiofrequency AblationRadiology 2015; 276(2): 426 doi: 10.1148/radiol.2015141695
18
Masato Higurashi, Tsuyoshi Maruyama, Yusuke Nogami, Fumihiro Ishikawa, Yukiko Yoshida, Kazunori Mori, Ken-ichi Fujita, Motoko Shibanuma. High expression of FOXM1 critical for sustaining cell proliferation in mitochondrial DNA-less liver cancer cellsExperimental Cell Research 2020; 389(1): 111889 doi: 10.1016/j.yexcr.2020.111889
19
Stacy K. Y. Fan, Brian Li, Qingyang Chen, Mehran Midia. Impact of Interventional Oncology Therapies on Tumor Microenvironment and Strategies to Enhance Their EfficacyAmerican Journal of Roentgenology 2018; 210(3): 648 doi: 10.2214/AJR.16.17677
20
Nicolò Gennaro, Simone Schiaffino, Giovanni Mauri, Lorenzo Monfardini. The What, the Why, and the How of Liver Ablations: A Practical Guide for the Medical OncologistOncology 2021; 99(11): 722 doi: 10.1159/000518358
21
Pankaj Gupta, Naveen Kalra, Sreedhara B. Chaluvashetty, Shivanand Gamangatti, Amar Mukund, Razik Abdul, VS Shyam, Sanjay Saran Baijal, Chander Mohan. Indian College of Radiology and Imaging Guidelines on Interventions in Hepatocellular CarcinomaIndian Journal of Radiology and Imaging 2022; 32(04): 540 doi: 10.1055/s-0042-1754361
22
Xingshun Qi, Yan Zhao, Hongyu Li, Xiaozhong Guo, Guohong Han. Management of hepatocellular carcinoma: an overview of major findings from meta-analysesOncotarget 2016; 7(23): 34703 doi: 10.18632/oncotarget.9157
23
Di Zhou, Gang-Feng Hu, Wei-Chen Gao, Xiao-Yu Zhang, Wen-Bin Guan, Jian-Dong Wang, Fei Ma. Hepatocellular carcinoma with tumor thrombus in bile duct: A proposal of new classification according to resectability of primary lesionWorld Journal of Gastroenterology 2020; 26(44): 7005-7021 doi: 10.3748/wjg.v26.i44.7005
24
Lumin Chen, Jihong Sun, Xiaoming Yang. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current statusCancer Letters 2016; 370(1): 78 doi: 10.1016/j.canlet.2015.09.020
25
Thuong G. Van Ha. Difficult Decisions in Hepatobiliary and Pancreatic SurgeryDifficult Decisions in Surgery: An Evidence-Based Approach 2016; : 139 doi: 10.1007/978-3-319-27365-5_12
26
Daniel Putzer, Peter Schullian, Gernot Eberle, Reto Josef Bale. Thermal ablation—an option in curative treatment of HCCmemo - Magazine of European Medical Oncology 2020; 13(2): 207 doi: 10.1007/s12254-020-00600-5
27
Emilio De Raffele. Liver Diseases2020; : 341 doi: 10.1007/978-3-030-24432-3_31
28
Shi-Lu Chen, Shi-Xun Lu, Li-Li Liu, Chun-Hua Wang, Xia Yang, Zhi-yi Zhang, Hui-Zhong Zhang, Jing-ping Yun. eEF1A1 Overexpression Enhances Tumor Progression and Indicates Poor Prognosis in Hepatocellular CarcinomaTranslational Oncology 2018; 11(1): 125 doi: 10.1016/j.tranon.2017.11.001
29
松 王. Study of Pleural Effusion after Radiofrequency Ablation for Primary Hepatocellular CarcinomaWorld Journal of Cancer Research 2017; 7(01): 6 doi: 10.12677/WJCR.2017.71002
30
Avik Majumdar, Davide Roccarina, Douglas Thorburn, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Management of people with early- or very early-stage hepatocellular carcinomaCochrane Database of Systematic Reviews 2017;  doi: 10.1002/14651858.CD011650.pub2
31
Karin Nielsen, Hester J. Scheffer, M. Petrousjka van den Tol, Anders Nilsson. Irreversible Electroporation in Clinical Practice2018; : 139 doi: 10.1007/978-3-319-55113-5_10
32
Masaya Miyazaki, Toshihiro Iguchi, Haruyuki Takaki, Takashi Yamanaka, Yoshitaka Tamura, Hiroyuki Tokue, Yozo Sato, Osamu Ikeda, Tadashi Shimizu, Koichiro Yamakado. Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese expertsJapanese Journal of Radiology 2016; 34(9): 647 doi: 10.1007/s11604-016-0569-8
33
Gastrointestinale Tumoren2018; : 397 doi: 10.1016/B978-3-437-21152-2.00009-8
34
Yi-xin Hu, Cui-ju Yan, Miao Yun, Wei Zheng, Xue-bin Zou, Ya-fang Zhang, Ru-shuang Mao, Ling-ling Li, Jian-hua Zhou. Contrast-enhanced ultrasound liver imaging reporting and data system v2017: patient outcomes after treatment for early-stage hepatocellular carcinoma nodules with category 3-5 and category MThe British Journal of Radiology 2023;  doi: 10.1259/bjr.20220492
35
Francesco Izzo, Vincenza Granata, Roberto Grassi, Roberta Fusco, Raffaele Palaia, Paolo Delrio, Gianpaolo Carrafiello, Daniel Azoulay, Antonella Petrillo, Steven A Curley. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An UpdateThe Oncologist 2019; 24(10): e990 doi: 10.1634/theoncologist.2018-0337
36
Tian Lan, Lei Chang, Rahmathullah MN, Long Wu, Yu-Feng Yuan. Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular CarcinomaMedicine 2016; 95(15): e3185 doi: 10.1097/MD.0000000000003185
37
Allison N. Martin, Luke R. Wilkins, Deepanjana Das, Lily E. Johnston, Todd W. Bauer, Reid B. Adams, Victor M. Zaydfudim. Efficacy of Radiofrequency Ablation versus Transarterial Chemoembolization for Patients with Solitary Hepatocellular Carcinoma ≤3 cmThe American Surgeon 2019; 85(2): 150 doi: 10.1177/000313481908500220
38
Shibin Du, Jian-Zhi Yang, Jing Chen, Wei-gang Zhou, Yan-Yan Sun, Scott M. Langevin. Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matchingPLOS ONE 2020; 15(1): e0227242 doi: 10.1371/journal.pone.0227242
39
Fuan Wang, Chuan Xu, Guiling Li, Penghua Lv, Jianping Gu. Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinomaExperimental Cell Research 2021; 409(2): 112910 doi: 10.1016/j.yexcr.2021.112910
40
Shiv Bahadur, Prashant Kumar. Deep Learning for Targeted Treatments2022; : 229 doi: 10.1002/9781119857983.ch8
41
Pankaj Gupta, Shyamkumar N. Keshava, Naveen Kalra, Sreedhara B. Chaluvashetty, Amar Mukund, Shuvro H. Roy-Choudhury, Sanjay Saran Baijal, Anubhav Khandelwal, Venkatesh Hosur Ananthashayana, Sathya Narayanan R., Suyash S. Kulkarni, Nitin Sudhakar Shetty, Arun Gupta, Sanjay Gupta. Indian Society of Vascular and Interventional Radiology Expert Consensus Statements for Ablation in Hepatocellular Carcinoma: Part IIJournal of Clinical Interventional Radiology ISVIR 2020; 4(03): 175 doi: 10.1055/s-0040-1715775
42
Bin Chai, Wei Wang, Fuquan Wang, Guofeng Zhou, Chuansheng Zheng. Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinomaInternational Journal of Hyperthermia 2021; 38(1): 1685 doi: 10.1080/02656736.2021.1970825